Oxelumab
From Wikipedia, the free encyclopedia
Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Human |
Target | OX-40 ligand |
Clinical data | |
Legal status | ? |
Identifiers | |
CAS number | 1186098-83-8 |
ATC code | None |
Chemical data | |
Formula | C6424H9920N1704O2014S42 |
Mol. mass | 144.6 kDa |
(what is this?) (verify) | |
Oxelumab is a human monoclonal antibody designed for the treatment of asthma.[1]
Oxelumab was developed by Genentech and co-developed by Roche.
References
- ↑ "Statement On A Nonproprietary Name Adopted By The USAN Council: Oxelumab". American Medical Association.
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.